[Table/Fig-4]:

Differences between C325T genotypes respect to sex in cases and controls

T2DM Patients	Males (n=138)	Females (n=112)	p-value	OR (CI=95%)	χ2
CC	79 (57.2%)	69 (61.6%)	Reference
CT	51 (37%)	36 (32.1%)	0.43	0.80 (0.4, 1.3)	0.6
TT	8 (5.8%)	7 (6.3%)	0.99	1.0 (0.3, 2.9)	0.001
CT+TT	59 (42.8%)	43 (38.3%)	0.48	0.8 (0.5, 1.3)	0.5
Controls	Males (n=144)	Females (n=106)	p-value	OR (CI=95%)	χ2
CC	92 (63.9%)	60 (56.6%)	Reference
CT	43 (29.9%)	36 (34%)	0.37	1.2 (0.7, 2.2)	0.8
TT	9 (6.2%)	10 (9.4%)	0.27	1.7 (0.6, 4.4)	1.2
CT+TT	52 (36.1%)	46 (43.4%)	0.24	1.3 (0.8, 2.2)	1.3

OR, Odds ratio, 95% CI- 95% confidence interval, χ2, Chi-square analysis calculated by SPSS v.19, calculated the SLC30A8 genotypes with gender between female’s vs males as males are higher in integer